Immune-mediated enterocolitis

1 trials MedDRA PT
1 Registered trials
0 Recruiting
1 Unique sponsors
1 Unique IMPs
1 Commercial trials
Drug classes (ATC)
— ATC code not specified 1
Mechanism of action (INN-stem analysis)
Unknown / small molecule 1 substance
Phase II: 1

Filter these 1 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 1 trials

Phase II

1 trial
  • Novartis Pharma AG Commercial
    HUMAN IGG1 MONOCLONAL ANTIBODY AGAINST HUMAN IL-1 BETA AND HUMAN IL-18
    2023-504419-34-00 4 countries 2021 n=7
    Ended
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Novartis Pharma AG Commercial 1 Phase II 0
New trials by year
2021
1
← All indication landscapes